Search Results for: fda

Surprising stem cell treatment poll results

Last week I posted a stem cell treatment poll. I was curious about people’s experiences and attitudes toward non-FDA approved stem cell treatments. During my time as a stem cell scientist and educator, I have met many people, some of whom have told me about their experiences with stem cell treatments. The results of the …

Surprising stem cell treatment poll results Read More »

A crazy week for stem cells: what the heck does it all mean?

This past week was a wacky and wild one for the stem cell field. All kinds of crazy things happened all in one week. What does it all mean? Stem cells the new steroids for sports? Reports surface this week that NY Yankees pitcher Bartolo Colon, had received a non-FDA approved stem cell treatment for …

A crazy week for stem cells: what the heck does it all mean? Read More »

CIRM funds $25 million for Geron trial, $38 million for basic biology

Geron-300x2212

CIRM announced two sets of awards today that both should make major impact including its first clinical trial via Geron and $38 million for 27 basic biology studies. First Clinical Trial. Today CIRM awarded $25 million to support Geron’s FDA-approved clinical trial for spinal cord injury. This is CIRM’s first award to a for-profit company …

CIRM funds $25 million for Geron trial, $38 million for basic biology Read More »

Myth of Perfect Stem Cell: meaning for ACT, Geron and field

in-science-we-trust

  There are a lot of myths in the stem cell field, some even embraced by some stem cell scientists such as the notion that teratoma are always benign. But when we start talking about translating stem cell technology into the clinic, to the bedside, it is especially important to cast aside our myths, no …

Myth of Perfect Stem Cell: meaning for ACT, Geron and field Read More »

Stem cell biotech updates: Geron, ACT, Neuralstem, Pfizer

What’s going on these days with biotech companies working on stem cell-based products? Geron’s and Advanced Cell Technology (ACT)’s FDA-approved trials presumably continue. As expected, no news yet. It’s too soon. Two important questions regarding both these companies are (1) did they apply for CIRM funding and (2) if so, how did the review process …

Stem cell biotech updates: Geron, ACT, Neuralstem, Pfizer Read More »

Stem Cells and Cars

It happens several times a month these days. Some new, interesting paper comes out on IPS cells or on transdifferentiation. Immediately, opponents of ES cell research criminally twist the findings in the new paper and produce ‘news’ headlines that pop up high on Google to the effect that ES cells are now ‘obsolete’. IPS cells …

Stem Cells and Cars Read More »

From Point A to Point Z: thinking outside the box about stem cells

What is the best way to get new stem cell-based therapies to the millions of patients who need help? I would argue that this is the key question in the field of stem cell biology and regenerative medicine. Sometimes I think it is easy for folks to lose sight of that and fall into traps. …

From Point A to Point Z: thinking outside the box about stem cells Read More »